Study of ZG006 in Participants With Small Cell Lung Cancer or Neuroendocrine Carcinoma
- Status
- RECRUITING
- Phase
- PHASE1/PHASE2
Clinical Trials Related to Small Cell Lung Cancer
Related studies linked through entity extraction aliases.
A Study of BL-B01D1, SI-B003 and BL-B01D1+SI-B003 in Patients With Extensive Stage Small Cell Lung Cancer
- Status
- RECRUITING
- Phase
- PHASE2
MOnaliZumab in Combination With durvAlumab (MEDI4736) for tRreatmenT of Small Cell Lung Cancer
- Status
- RECRUITING
- Phase
- PHASE2
Rapid Autopsy Protocol for Patients With Small Cell Lung Cancer
- Status
- RECRUITING
- Phase
- N/A
A Clinical Study on Oncolytic Virus Injection (R130) for the Treatment of Relapsed/Refractory Advanced Solid Tumors
- Status
- UNKNOWN
- Phase
- EARLY_PHASE1
Surufatinib Combined With Serplulimab Plus Chemotherapy in the Treatment of Extensive-stage Small Cell Lung Cancer
- Status
- NOT_YET_RECRUITING
- Phase
- PHASE1/PHASE2
Study of the CHK1 Inhibitor BBI-355, an ecDNA-directed Therapy (ecDTx), and the RNR Inhibitor BBI-825, in Subjects With Tumors With Oncogene Amplifications
- Status
- TERMINATED
- Phase
- PHASE1
Panomic Approach to Immune-Connected Assays in Small Cell Lung Cancer
- Status
- RECRUITING
- Phase
- N/A
Study of JANX008 in Subjects With Advanced or Metastatic Solid Tumor Malignancies
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE1
IMM2520, a PD-L1 and CD47 Bispecific Antibody in Patients With Advanced Solid Tumors
- Status
- RECRUITING
- Phase
- PHASE1
Examining Clinical Trial Participation for Small Cell Lung Cancer Patients
- Status
- NOT_YET_RECRUITING
- Phase
- N/A
SC0245 and Irinotecan in Treating Patients With Relapsed Extensive-Stage Small Cell Lung Cancer (ES-SCLC)
- Status
- RECRUITING
- Phase
- PHASE1/PHASE2
Development and Validation of Nomogram Predicting Survival in Chinese SCLC Patients
- Status
- COMPLETED
- Phase
- N/A
TRAcking Thoracic Cancer Evolution Through Therapy (Rx) EVO
- Status
- RECRUITING
- Phase
- N/A
Proteomics in Small Cell Lung Cancer
- Status
- RECRUITING
- Phase
- N/A
A Study to Evaluate Safety, Tolerability, Pharmacokinetics, Pharmacodynamics, and Preliminary Anti-tumor Activity of RO7616789 in Advanced Small Cell Lung Cancer and Other Neuroendocrine Carcinomas
- Status
- COMPLETED
- Phase
- PHASE1
Surufatinib Combined With Irinotecan as a Second-line Treatment for Small Cell Lung Cancer
- Status
- UNKNOWN
- Phase
- PHASE2
Lurbinectedin Combined With Durvalumab in Pre-treated Patients With Extensive Stage Small-cell Lung Cancer
- Status
- WITHDRAWN
- Phase
- PHASE2
89Zr-girentuximab for PET Imaging of CAIX Positive Solid Tumors
- Status
- TERMINATED
- Phase
- PHASE2
Immunological Variables Associated to ICI Toxicity in Cancer Patients
- Status
- UNKNOWN
- Phase
- PHASE2